Brief: NGM Bio Appoints Siobhan Nolan Mangini To President, Chief Financial Officer
30/06/2022 13:12
June 30 (Reuters) - NGM Biopharmaceuticals Inc NGM.O :
* NGM BIO APPOINTS SIOBHAN NOLAN MANGINI TO PRESIDENT AND
CHIEF
FINANCIAL OFFICER
* NGM BIOPHARMACEUTICALS INC - SIOBHAN NOLAN MANGINI HAS
BEEN
APPOINTED PRESIDENT OF NGM BIO
* NGM BIOPHARMACEUTICALS INC - DAVID J. WOODHOUSE, PH.D.
WILL
CONTINUE TO SERVE AS NGM BIO'S CHIEF EXECUTIVE OFFICER
* NGM BIOPHARMACEUTICALS INC - WILLIAM J. RIEFLIN WILL
TRANSITION
TO CHAIRMAN OF BOARD EFFECTIVE JULY 1, 2022
Source text for Eikon: ID:nGNXc0rLdr
Further company coverage: NGM.O
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors